Ozempic-Maker Novo Nordisk Says Data Leaked in Cyber Incident
3 Articles
3 Articles
Pharma giant Novo Nordisk discloses breach of clinical trials data
Danish pharmaceutical giant Novo Nordisk, the world’s largest producer of insulin, disclosed a data breach affecting patient information from some clinical trials. Founded in 1923, Novo Nordisk now employs around 67,900 people across 80 offices worldwide and is the maker of viral GLP-1 receptor agonist drugs Wegovy and Ozempic. The company revealed on Thursday that attackers gained access to its internal IT systems and data related to patients p…
Novo Nordisk Faces a Defining Quarter: Medicare Catalyst Clashes With Cyber Attack and Profit Squeeze
Exactly one year after touching an all‑time high above €70, Novo Nordisk’s shares now change hands at just over €38 — a 46% decline that reflects mounting competitive fears, a cyber incident, and structural price pressure. Yet the stock’s recent stabilization around its 50‑day moving average masks a more nuanced picture: the Danish drugmaker is […] The post Novo Nordisk Faces a Defining Quarter: Medicare Catalyst Clashes With Cyber Attack and Pr…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
